Tag #Intuitive Surgical

Showing 1 to 4 of 4 results

cnbc.com

🌐 75% Global Worthiness

Feb 2, 16:10

Analyst Upgrades Boost Netflix, Intuitive Surgical, and Twilio Stocks

JPMorgan and Goldman Sachs analysts upgraded Netflix, Intuitive Surgical, and Twilio stocks in late January 2025, citing strong Q4 2024 results, positive future outlooks, and strategic initiatives that outweigh recent market volatility.

Analyst Upgrades Boost Netflix, Intuitive Surgical, and Twilio Stocks

JPMorgan and Goldman Sachs analysts upgraded Netflix, Intuitive Surgical, and Twilio stocks in late January 2025, citing strong Q4 2024 results, positive future outlooks, and strategic initiatives that outweigh recent market volatility.

Progress

24% Bias Score

ShareSaveArticle

Decent Work and Economic Growth

12345678

Previous 1 of 8 Next

How do the analysts' long-term growth projections for these companies align with the current market volatility, and what are the potential risks?

Analyst upgrades for NFLX, ISRG, and TWLO showcase a focus on companies demonstrating robust financial performance and strategic initiatives. Netflix's subscriber growth, Intuitive Surgical's system placements, and Twilio's cost reduction measures drove positive assessments, highlighting the importance of strong fundamentals and strategic execution in a volatile market.

forbes.com

🌐 85% Global Worthiness

Jan 23, 16:14

Intuitive Surgical Earnings Preview: Record High, Volatility Expected

Intuitive Surgical (ISRG) is scheduled to release its Q[quarter] earnings after Thursday's market close; analysts predict $1.77 EPS on $2.21 billion in revenue, while the whisper number is $2.02 EPS; the stock is highly sensitive to results and recently reached a record high.

Intuitive Surgical Earnings Preview: Record High, Volatility Expected

Intuitive Surgical (ISRG) is scheduled to release its Q[quarter] earnings after Thursday's market close; analysts predict $1.77 EPS on $2.21 billion in revenue, while the whisper number is $2.02 EPS; the stock is highly sensitive to results and recently reached a record high.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

Considering ISRG's historical earnings growth and current P/E ratio, what are the key factors influencing its valuation and future growth potential?

ISRG's strong historical earnings growth (from $3.03 EPS in 2017 to $5.71 in 2023, with projections of $6.91 in 2024 and $7.93 in 2025) and high P/E ratio (90, 3.6x the S&P 500) highlight its market position and growth potential. However, the stock's current overbought state suggests a potential pullback if earnings disappoint.

cnbc.com

🌐 75% Global Worthiness

Jan 25, 07:06

Premarket Movers: Boeing, Novo Nordisk, Twilio Lead

Premarket trading saw significant stock movements: Boeing fell 1.3% due to disappointing Q4 results; Novo Nordisk jumped 14% following positive obesity drug trial data; Twilio rallied 18% on an optimistic future forecast; CSX dropped 3.5% on lower revenue; and Texas Instruments slumped 4% after a we...

Premarket Movers: Boeing, Novo Nordisk, Twilio Lead

Premarket trading saw significant stock movements: Boeing fell 1.3% due to disappointing Q4 results; Novo Nordisk jumped 14% following positive obesity drug trial data; Twilio rallied 18% on an optimistic future forecast; CSX dropped 3.5% on lower revenue; and Texas Instruments slumped 4% after a we...

Progress

32% Bias Score

ShareSaveArticle

Decent Work and Economic Growth

12345678

Previous 1 of 8 Next

What are the key factors driving the significant premarket stock price changes in Boeing, Novo Nordisk, and Twilio?

Boeing's preliminary fourth-quarter results revealed a projected loss of $5.46 per share and $3.5 billion in cash burn, leading to a 1.3% premarket stock decline. Novo Nordisk saw a 14% surge due to positive early-stage trial results for its obesity drug, showing a 22% average weight reduction. Twilio rallied almost 18% after issuing an optimistic forecast for the next few years, projecting a 22% adjusted operating margin by 2027.

cnbc.com

🌐 75% Global Worthiness

Jan 8, 22:08

Intuitive Surgical (ISRG) Stock Outperforms Healthcare Sector Amidst Market Downturn

Intuitive Surgical (ISRG) stock, a component of the iShares U.S. Medical Devices ETF (IHI), is outperforming other healthcare stocks and ETFs, approaching its all-time high despite recent market volatility, and is expected to reach a target of $580 if it surpasses the $550 zone.

Intuitive Surgical (ISRG) Stock Outperforms Healthcare Sector Amidst Market Downturn

Intuitive Surgical (ISRG) stock, a component of the iShares U.S. Medical Devices ETF (IHI), is outperforming other healthcare stocks and ETFs, approaching its all-time high despite recent market volatility, and is expected to reach a target of $580 if it surpasses the $550 zone.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What factors explain Intuitive Surgical's (ISRG) resilience against the broader healthcare market downturn?

Despite recent market downturns affecting many healthcare stocks, Intuitive Surgical (ISRG) remains a strong performer, nearing its all-time high and recently breaking out from bullish patterns. Its price has consistently rebounded after temporary dips below its 50-day moving average, suggesting resilience.

Showing 1 to 4 of 4 results